Literature DB >> 29341117

HOXD-AS1/miR-130a sponge regulates glioma development by targeting E2F8.

Yinan Chen1, Fengbo Zhao2, Daming Cui3, Rui Jiang1, Jian Chen1, Qingfeng Huang1, Jinlong Shi1.   

Abstract

Glioma development is an extremely complex process with changes occurring in numerous genes. HOXD antisense growth-associated long noncoding RNA (HOXD-AS1), an important long noncoding RNA (lncRNA), is known to regulate metastasis-related gene expression in bladder cancer, ovarian cancer and neuroblastoma. Here, we elucidated the function and possible molecular mechanisms of lncRNA HOXD-AS1 in human glioma cells. Our results proved that HOXD-AS1 expression was upregulated in glioma tissues and in glioma cell lines. HOXD-AS1 overexpression promoted cell migration and invasion in vitro, whereas knockdown of HOXD-AS1 expression repressed these cellular processes. Mechanistic studies further revealed that HOXD-AS1 could compete with the transcription factor E2F8 to bind with miR-130a, thus affecting E2F8 expression. Additionally, reciprocal repression was observed between HOXD-AS1 and miR-130a, and miR-130a mediated the tumor-suppressive effects of HOXD-AS1 knockdown. Taken together, these results provide a comprehensive analysis of the role of HOXD-AS1 in glioma cells and offer important clues to understand the key roles of competing endogenous RNA (ceRNA) mechanisms in human glioma.
© 2018 UICC.

Entities:  

Keywords:  E2F8; HOXD-AS1; ceRNA; lncRNA; miR-130a

Mesh:

Substances:

Year:  2018        PMID: 29341117     DOI: 10.1002/ijc.31262

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  26 in total

1.  A positive feedback loop involving the LINC00346/β-catenin/MYC axis promotes hepatocellular carcinoma development.

Authors:  Nuobei Zhang; Xin Chen
Journal:  Cell Oncol (Dordr)       Date:  2019-11-05       Impact factor: 6.730

Review 2.  Novel insights into the interaction between long non-coding RNAs and microRNAs in glioma.

Authors:  Anahita Ebrahimpour; Mohammad Sarfi; Setareh Rezatabar; Sadra Samavarchi Tehrani
Journal:  Mol Cell Biochem       Date:  2021-02-13       Impact factor: 3.396

3.  Promoter and enhancer RNAs regulate chromatin reorganization and activation of miR-10b/HOXD locus, and neoplastic transformation in glioma.

Authors:  Evgeny Deforzh; Erik J Uhlmann; Eashita Das; Aleksandra Galitsyna; Ramil Arora; Harini Saravanan; Rosalia Rabinovsky; Aditya D Wirawan; Nadiya M Teplyuk; Rachid El Fatimy; Sucika Perumalla; Anirudh Jairam; Zhiyun Wei; Leonid Mirny; Anna M Krichevsky
Journal:  Mol Cell       Date:  2022-04-06       Impact factor: 19.328

Review 4.  There and Back Again: Hox Clusters Use Both DNA Strands.

Authors:  Elena L Novikova; Milana A Kulakova
Journal:  J Dev Biol       Date:  2021-07-15

5.  LINC00641/miR-4262/NRGN axis confines cell proliferation in glioma.

Authors:  Jinghui Yang; Duo Yu; Xueshibojie Liu; E Changyong; Shan Yu
Journal:  Cancer Biol Ther       Date:  2020-06-16       Impact factor: 4.742

Review 6.  Role of noncoding RNA in drug resistance of prostate cancer.

Authors:  Lifeng Ding; Ruyue Wang; Danyang Shen; Sheng Cheng; Huan Wang; Zeyi Lu; Qiming Zheng; Liya Wang; Liqun Xia; Gonghui Li
Journal:  Cell Death Dis       Date:  2021-06-08       Impact factor: 8.469

7.  WZY-321 triggers glioma cell apoptosis via XAF1 up-regulation caused by MTM-mediated miR-873 down-regulation.

Authors:  Guan Sun; Wei Yuan; Weiye Zhu; Jian Chen
Journal:  J Cancer       Date:  2022-04-18       Impact factor: 4.478

Review 8.  Noncoding RNA:RNA Regulatory Networks in Cancer.

Authors:  Jia Jia Chan; Yvonne Tay
Journal:  Int J Mol Sci       Date:  2018-04-27       Impact factor: 5.923

9.  LncRNA FAM83H-AS1 promotes oesophageal squamous cell carcinoma progression via miR-10a-5p/Girdin axis.

Authors:  Bo Feng; Gaoyan Wang; Xiaoliang Liang; Zheng Wu; Xinchen Wang; Zhiming Dong; Yanli Guo; Supeng Shen; Jia Liang; Wei Guo
Journal:  J Cell Mol Med       Date:  2020-06-24       Impact factor: 5.310

10.  LncRNA-NNT-AS1 contributes to the progression of glioma by miR-582-5p/EZH2 axis.

Authors:  Tonglin Pan; Min Xue
Journal:  Cytotechnology       Date:  2021-04-28       Impact factor: 2.040

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.